Pursuant to Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 we hereby inform that Mr. N. Govindarajan (DIN: 00050482) has tendered his resignation as the Managing Director and a Director on the Board of the Company due to personal reasons. His resignation was considered and accepted by the Board of Directors in its meeting today. Mr. N. Govindarajan will be relieved from the services of the Company effective from the close of business on December 31 2021.
The Board has also taken note of the appointment of Mr. S. Damodharan as Chief Operating Officer (COO) for the API vertical.
The Board has further taken note of the appointment of Mr. P. Yugandhar as the Chief Executive Officer (CEO) of Eugia Pharma Specialities Limited a wholly owned subsidiary of the Company focused on generic injectables and oncology business.
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
